Dette fald var signifikant blandt de responderende (- 0, 3 for Metavir og - 1, 2 for Ishak) og stabile (- 0, 1 for Metavir og - 0, 2 for Ishak) blandt de ikke- responderende.
This decline was significant among responders (- 0.3 for Metavir and -1.2 for Ishak) and stable (-0.1 for Metavir and -0.2 for Ishak) among non- responders.